(Q28678663)
Statements
2 references
Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects (English)
2 references
Patricia St Clair
Mark X Sliwkowski
Michael G Brattain
1 April 2004
2 references
2 references
64
2 references
7
2 references
Identifiers
2 references